Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women
Launched by SIBEL HEALTH INC. · Mar 15, 2023
Trial Information
Current as of October 01, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age \>= 18 years old
- • Ability and willingness to provide written informed consent
- • Admitted for delivery at UNC Medical Center
- • BMI of \>= 40 kg/m2
- • Clinically indicated radial A-lines either planned or already in-situ prior to delivery
- Exclusion Criteria:
- • Skin sensitivity or allergy that precludes placement of ANNE One
- • Any condition (social or medical) which, in the opinion of the study staff would make any study participation unsafe or complicate data interpretation
- • Expected delivery within \<= 1 hour of arrival to L\&D
About Sibel Health Inc.
Sibel Health Inc. is an innovative healthcare technology company focused on transforming patient monitoring through advanced wearable devices and real-time data analytics. By leveraging its proprietary platform, Sibel Health aims to enhance clinical decision-making and improve patient outcomes in various healthcare settings. The company is dedicated to fostering collaboration between healthcare providers and patients, ensuring seamless integration of its solutions into existing clinical workflows. With a commitment to advancing personalized medicine, Sibel Health is at the forefront of redefining patient care through cutting-edge technology and data-driven insights.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials